Abstract |
A panel of nine dibenzo[a,c]cyclooctadiene lignans, schizandrin, gomisin A, gomisin N, gomisin J, angeloylgomisin H, tigloylgomisin P, deoxyschizandrin, gamma-schizandrin and wuweizisu C was examined for their effect on multidrug resistance, as well as their anti-proliferative activities. COR-L23/R, a multidrug resistant sub-line, which has been reported to over-express multidrug resistance-associated protein ( MRP1), was used for the experiments together with its parent cell line COR-L23 (human lung cell carcinoma). We found that lignans deoxyschizandrin and gamma-schizandrin at relatively non-toxic concentrations restored the cytotoxic action of doxorubicin to COR-L23/R cells. Deoxyschizandrin and gamma-schizandrin also significantly enhanced the accumulation of doxorubicin in drug resistant cells. Both lignans alone had no effect on the cell cycle; however, when combined with sub-toxic doses of doxorubicin, they induced cell cycle arrest in the G2/M phase, which is typical for toxic doses of doxorubicin. Our results suggest that deoxyschizandrin and gamma-schizandrin potentiate the cytotoxic effect of doxorubicin in doxorubicin resistant lung cancer cells COR-L23/R by increasing the accumulation of doxorubicin inside the cells. The common structural feature of both active lignans is the R-biaryl configuration and the absence of a hydroxy group at C-8. Unlike the reversal effect, the cytotoxicity of lignans with the R-biaryl configuration was similar to that observed for lignans with the S-biaryl configuration.
|
Authors | I Slaninová, L Brezinová, L Koubíková, J Slanina |
Journal | Toxicology in vitro : an international journal published in association with BIBRA
(Toxicol In Vitro)
Vol. 23
Issue 6
Pg. 1047-54
(Sep 2009)
ISSN: 1879-3177 [Electronic] England |
PMID | 19531378
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antibiotics, Antineoplastic
- Cyclooctanes
- Lignans
- dibenzocyclooctadiene lignan
- Doxorubicin
|
Topics |
- Antibiotics, Antineoplastic
(administration & dosage, metabolism, pharmacology)
- Carcinoma, Large Cell
(drug therapy, metabolism)
- Cell Division
(drug effects)
- Cell Line, Tumor
- Cyclooctanes
(administration & dosage, chemistry, pharmacology)
- Dose-Response Relationship, Drug
- Doxorubicin
(administration & dosage, metabolism, pharmacology)
- Drug Resistance, Multiple
(drug effects)
- Drug Resistance, Neoplasm
(drug effects)
- G2 Phase
(drug effects)
- Humans
- Lignans
(administration & dosage, chemistry, pharmacology)
- Lung Neoplasms
(drug therapy, metabolism)
- Structure-Activity Relationship
|